Thalidomide in multiple myeloma

This publication has 63 references indexed in Scilit:

• Thalidomide in the Treatment of Relapsed Multiple Myeloma
  Mayo Clinic Proceedings, 2000
• Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
  New England Journal of Medicine, 1999
• Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
  Journal of the American Academy of Dermatology, 1996
• Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide
  Chirality, 1995
• Thalidomide and the immune system 3. simultaneous up- and down-regulation of different integrin receptors on human white blood cells
  Life Sciences, 1994
• Bone marrow angiogenesis and progression in multiple myeloma
  British Journal of Haematology, 1994
• Thalidomide is an inhibitor of angiogenesis.
  Proceedings of the National Academy of Sciences, 1994
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
  The Journal of Experimental Medicine, 1993
• Thalidomide-induced peripheral neuropathy. Effect of serum factor on nerve cultures
  Archives of Dermatology, 1984
• Thalidomide in Rabbit Semen
  Nature, 1967